This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
BNO Aperçu des actions
A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers.
| Score flocon de neige | |
|---|---|
| Évaluation | 2/6 |
| Croissance future | 0/6 |
| Performances passées | 0/6 |
| Santé financière | 6/6 |
| Dividendes | 0/6 |
Bionomics Limited Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | AU$0.01 |
| Plus haut sur 52 semaines | AU$0.074 |
| Plus bas sur 52 semaines | AU$0.009 |
| Bêta | 2.13 |
| 1Variation sur 1 mois | -16.67% |
| Variation sur 3 mois | -52.38% |
| Variation sur 1 an | -81.13% |
| 3Variation sur 3 ans | -92.86% |
| Variation sur 5 ans | -98.10% |
| Évolution depuis l'introduction en bourse | -98.48% |
Nouvelles et mises à jour récentes
Recent updates
Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Jun 14
Is Bionomics (ASX:BNO) In A Good Position To Invest In Growth?
Feb 23Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Sep 14Companies Like Bionomics (ASX:BNO) Are In A Position To Invest In Growth
Nov 15Did You Miss Bionomics' (ASX:BNO) 86% Share Price Gain?
Dec 30Rendement pour les actionnaires
| BNO | AU Biotechs | AU Marché | |
|---|---|---|---|
| 7D | 0% | 1.6% | 0.6% |
| 1Y | -81.1% | 32.6% | 19.9% |
Rendement vs Industrie: BNO underperformed the Australian Biotechs industry which returned -9.1% over the past year.
Rendement vs marché: BNO underperformed the Australian Market which returned 1.8% over the past year.
Volatilité des prix
| BNO volatility | |
|---|---|
| BNO Average Weekly Movement | 24.4% |
| Biotechs Industry Average Movement | 10.4% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in AU Market | 17.7% |
| 10% least volatile stocks in AU Market | 3.6% |
Cours de l'action stable: BNO's share price has been volatile over the past 3 months.
Volatilité au fil du temps: BNO's weekly volatility has increased from 18% to 24% over the past year.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1996 | n/a | Spyros Papapetropoulos | www.bionomics.com.au |
Bionomics Limited Résumé des fondamentaux
| BNO statistiques fondamentales | |
|---|---|
| Capitalisation boursière | AU$14.69m |
| Bénéfices(TTM) | -AU$24.91m |
| Recettes(TTM) | AU$6.02m |
2.4x
Ratio P/S-0.6x
Ratio P/ELe site BNO est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| BNO compte de résultat (TTM) | |
|---|---|
| Recettes | AU$6.02m |
| Coût des recettes | AU$19.80m |
| Marge brute | -AU$13.79m |
| Autres dépenses | AU$11.13m |
| Les revenus | -AU$24.91m |
Derniers bénéfices déclarés
Dec 31, 2022
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | -0.017 |
| Marge brute | -229.04% |
| Marge bénéficiaire nette | -413.94% |
| Ratio dettes/capitaux propres | 0% |
Quelles ont été les performances à long terme de BNO?
Voir les performances historiques et les comparaisons